Related references
Note: Only part of the references are listed.Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI
Zicheng Wei et al.
JOURNAL OF INVESTIGATIVE SURGERY (2021)
Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway
Jun Gao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
Circular RNA circ_0000039 enhances gastric cancer progression through miR-1292-5p/DEK axis
Dengguo Fan et al.
CANCER BIOMARKERS (2021)
Circulating microRNA Panel as a Potential Novel Biomarker for Oral Squamous Cell Carcinoma Diagnosis
Kodai Nakamura et al.
CANCERS (2021)
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
Maurizia Mello-Grand et al.
FRONTIERS IN ONCOLOGY (2021)
The lnc-CTSLP8 upregulates CTSL1 as a competitive endogenous RNA and promotes ovarian cancer metastasis
Xinjing Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1
Kai Chen et al.
ONCOGENE (2021)
Dysregulations of long non-coding RNAs-The emerging lnc in environmental carcinogenesis
Po-Shun Wang et al.
SEMINARS IN CANCER BIOLOGY (2021)
Gastritis, Gastric Polyps and Gastric Cancer
Helge Waldum et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p
Tieying Hou et al.
ONCOTARGETS AND THERAPY (2021)
Comprehensive Analysis of E2F Family Members in Human Gastric Cancer
Shengbo Li et al.
FRONTIERS IN ONCOLOGY (2021)
Ischemia-induced upregulation of autophagy preludes dysfunctional lysosomal storage and associated synaptic impairments in neurons
Xia Zhang et al.
AUTOPHAGY (2021)
MiR-450a-5p inhibits autophagy and enhances radiosensitivity by targeting dual-specificity phosphatase 10 in esophageal squamous cell carcinoma
Hui Chen et al.
CANCER LETTERS (2020)
Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway
Hua He et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2020)
Regulatory Mechanism of MicroRNA Expression in Cancer
Zainab Ali Syeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Long noncoding RNA LEF1-AS1 binds with HNRNPL to boost the proliferation, migration, and invasion in osteosarcoma by enhancing the mRNA stability of LEF1
Xiangdong Lu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7
Jun Gao et al.
CELL CYCLE (2020)
MKL1/miR-5100/CAAP1 loop regulates autophagy and apoptosis in gastric cancer cells
Hui-Min Zhang et al.
NEOPLASIA (2020)
LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2
Shi Zeng et al.
BRAIN RESEARCH (2020)
被撤回的出版物: MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK (Retracted article. See vol. 15, pg. 487, 2023)
Wei Zhang et al.
CANCER MANAGEMENT AND RESEARCH (2020)
CD36 upregulates DEK transcription and promotes cell migration and invasion via GSK-3β/β-catenin-mediated epithelial-to-mesenchymal transition in gastric cancer
Jin Wang et al.
Aging-US (2020)
LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway
Weiyuan Li et al.
CANCER CELL INTERNATIONAL (2020)
Development of miRNA-based therapeutic approaches for cancer patients
Ryou-u Takahashi et al.
CANCER SCIENCE (2019)
LEF1-AS1 contributes to proliferation and invasion through regulating miR-544a/FOXP1 axis in lung cancer
Ansheng Wang et al.
INVESTIGATIONAL NEW DRUGS (2019)
LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy
Ada Congrains-Castillo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT
Xina Zhang et al.
MOLECULAR CANCER (2019)
DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma
Kam-Fai Lee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression
Da-Chuang Liu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma
Jianbo Shi et al.
THERANOSTICS (2019)
Long noncoding RNAs: a missing link in osteoporosis
Andreia Machado Silva et al.
BONE RESEARCH (2019)
MiR-5100 increases the cisplatin resistance of the lung cancer stem cells by inhibiting the Rab6
Lawei Yang et al.
MOLECULAR CARCINOGENESIS (2018)
The Complexity of DEK Signaling in Cancer Progression
Yong Teng et al.
CURRENT CANCER DRUG TARGETS (2018)
Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells
Gaofeng Liang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
MiR-5100 promotes osteogenic differentiation by targeting Tob2
Huaxin Wang et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
Co-expression network analysis of long noncoding RNAs (IncRNAs) and cancer genes revealsSFTA1P and CASC2abnormalities in lung squamous cell carcinoma
Guang-Qing Huang et al.
CANCER BIOLOGY & THERAPY (2017)
Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma
Xin Liu et al.
ONCOLOGY REPORTS (2016)
Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL
Yoshiro Chijiiwa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Regulation of DEK expression by AP-2α and methylation level of DEK promoter in hepatocellular carcinoma
Ming-Xu Qiao et al.
ONCOLOGY REPORTS (2016)
Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma
Yingfu Ou et al.
ONCOLOGY LETTERS (2016)
Critical role of DEK and its regulation in tumorigenesis and metastasis of hepatocellular carcinoma
Le Yu et al.
ONCOTARGET (2016)
Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
Jingjing Duan et al.
ONCOTARGET (2016)
Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
Haiyang Zhang et al.
PROTEIN & CELL (2016)
The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression
Cheng-Cao Sun et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications
Sujuan Guo et al.
AUTOPHAGY (2015)
miR-1182 attenuates gastric cancer proliferation and metastasis by targeting the open reading frame of hTERT
Dan Zhang et al.
CANCER LETTERS (2015)
miR-5100 promotes tumor growth in lung cancer by targeting Rab6
Haili Huang et al.
CANCER LETTERS (2015)
microRNA regulation of Wnt signaling pathways in development and disease
Jia L. Song et al.
CELLULAR SIGNALLING (2015)
MicroRNAs: Emerging Role in the Endogenous μ Opioid System
Massmo Barbierato et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival
Allie K. Adams et al.
ONCOTARGET (2015)
The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress
A. Deutzmann et al.
ONCOGENE (2015)
Deregulation between miR-29b/c and DNMT3A Is Associated with Epigenetic Silencing of the CDH1 Gene, Affecting Cell Migration and Invasion in Gastric Cancer
He Cui et al.
PLoS One (2015)
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
Junjie Piao et al.
DIAGNOSTIC PATHOLOGY (2014)
miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase
L. Chen et al.
CELL DEATH & DISEASE (2014)
DEK over expression as an independent biomarker for poor prognosis in colorectal cancer
Lijuan Lin et al.
BMC CANCER (2013)
Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR
Carl Sanden et al.
BMC CANCER (2013)
Mechanisms of chemoresistance in cancer stem cells
Lissa Nurrul Abdullah et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
C/EBPα and DEK coordinately regulate myeloid differentiation
Rositsa I. Koleva et al.
BLOOD (2012)
Expression level of DEK in chronic lymphocytic leukemia is regulated by fludarabine and Nutlin-3 depending on p53 status
Dong-Mei Wang et al.
CANCER BIOLOGY & THERAPY (2012)
Life in the balance - a mechanistic view of the crosstalk between autophagy and apoptosis
Assaf D. Rubinstein et al.
JOURNAL OF CELL SCIENCE (2012)
The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer
Lisa M. Privette Vinnedge et al.
PLOS ONE (2012)
Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia
Andrea Kuehnl et al.
BLOOD (2011)
The human DEK oncogene stimulates β-catenin signaling, invasion and mammosphere formation in breast cancer
L. M. Privette Vinnedge et al.
ONCOGENE (2011)
Melanoma Proliferation and Chemoresistance Controlled by the DEK Oncogene
Michael S. Khodadoust et al.
CANCER RESEARCH (2009)
Clinicopathological significance of DEK overexpression in serous ovarian tumors
Songying Han et al.
PATHOLOGY INTERNATIONAL (2009)
Autophagy fights disease through cellular self-digestion
Noboru Mizushima et al.
NATURE (2008)
Apoptosis inhibition by the human DEK oncoprotein involves interference with p53 functions
Trisha M. Wise-Draper et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene
Morgan Sammons et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma
C Grasemann et al.
ONCOGENE (2005)
Human Ku70/80 interacts directly with hTR, the RNA component of human telomerase
NSY Ting et al.
NUCLEIC ACIDS RESEARCH (2005)
Defining a 0.5-Mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction
AJ Evans et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
The identification of novel therapeutic targets for the treatment of malignant brain tumors
RA Kroes et al.
CANCER LETTERS (2000)
Share Paper
